Covered recipient · General Payments record
WILLIAM GRACE
General Payments · PY2018–2023
$9,845.03
- Reported across 550 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $200.00 | 1 |
| Food and Beverage | $155.59 | 7 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $200.00 | 1 |
| Acerta Pharma LLC | $71.68 | 3 |
| Mirati Therapeutics, Inc. | $46.75 | 2 |
| Astellas Pharma US Inc | $37.16 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (8)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20182019202020212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $18.28 | 06/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034133619 | CMS |
| Astellas Pharma US Inc | $18.88 | 07/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034338651 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.39 | 05/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1024996135 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.60 | 06/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1024984309 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.69 | 09/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1025042809 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $200.00 | 10/25/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1000011943 | CMS |
| Mirati Therapeutics, Inc. | $22.88 | 04/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057991679 | CMS |
| Mirati Therapeutics, Inc. | $23.87 | 06/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057991681 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.